Related Experiment Video

Updated: Aug 23, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection

Christopher J Gill1, Lora L Sabin, Joseph Tham

  • 1Department of International Health, Center for International Health and Development, Boston University School of Public Health, Boston, MA, USA. cgill@bu.edu

Bulletin of the World Health Organization
|July 21, 2004
PubMed

Insights

Mass cotrimoxazole prophylaxis for infants of HIV-positive mothers may be counterproductive. This approach risks antibiotic resistance, potentially outweighing benefits for infant Pneumocystis pneumonia prevention.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Infants born to HIV-positive mothers are at high risk for Pneumocystis pneumonia (PCP) within their first year.
  • Current guidelines recommend prophylactic cotrimoxazole for all infants exposed to HIV.
  • This empirical prophylaxis strategy balances infant protection against potential risks like antimicrobial resistance.

Purpose of the Study:

  • To critically analyze the literature on mass cotrimoxazole prophylaxis in infants of HIV-positive mothers.
  • To develop a conceptual model illustrating potential counterproductive outcomes of this policy.

Main Methods:

  • Literature review and critical analysis.
  • Development of a conceptual model based on existing evidence.

Main Results:

  • Empirical mass prophylaxis presents a trade-off between infant benefit and the risk of developing resistance.
  • Under specific conditions, widespread cotrimoxazole use may prove detrimental rather than beneficial.

Conclusions:

  • The current policy of mass cotrimoxazole prophylaxis for infants of HIV-positive mothers requires careful consideration.
  • Potential for counterproductive effects, particularly regarding antimicrobial resistance, necessitates further evaluation and alternative strategies.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...